Medical Director, Ann B Barshinger Cancer Institute, Lancaster General Health, Director of Oncology Research, Lancaster General Health, Chair, Institutional Review Board, Lancaster General Health

Radiation Oncology

Jeffrey S. Eshleman, MD practices Radiation Oncology. He attended Drexel University College of Medicine. He over the years received 13 awards: "Gordon Conference Travel Award for presentation Substrate screen for hChk1 and hChk2 kinase activity", "Chief Resident", "Jane Stuart Award for Excellence in Radiation Oncology and Nuclear Medicine", "Distinguished Academic Performance for Outstanding Academic Performance in the Field of Neoplastic Disease", "Distinguished Academic Performance for Outstanding Academic Performance in the Field of Radiation Therapy and Nuclear Medicine", "Alpha Omega Alpha, junior year", "Pathology Honor Society", "Measy Foundation Scholarship", "Deans Award for Research", "Class of 1955 Scholarship", "L. & M. Scholarship", "Dr. H. Malcolm Read Scholarship" and "McMannis Scholarship". Jeffrey S. Eshleman, MD is a published doctor. He published 7 publications, including: 'Adjuvant whole brain radiotherapy: strong emotions decide but rationale studies are needed: in regard to Brown et al. (Int J Radiat Oncol Biol Phys 2008;70:1305-1309)....' He is registered with Medicare and accepts Medicare payments.

Publications

---

• Adjuvant whole brain radiotherapy: strong emotions decide but rationale studies are needed: in regard to Brown et al. (Int J Radiat Oncol Biol Phys 2008;70:1305-1309)....
• Radioactive seed migration to the chest after transperineal interstitial prostate brachytherapy: extraprostatic seed placement correlates with migration.
• Inhibition of the mammalian target of rapamycin sensitizes U87 xenografts to fractionated radiation therapy.
• Prostate brachytherapy seed migration to the right ventricle found at autopsy following acute cardiac dysrhythmia.
• An analysis of facial nerve function in irradiated and unirradiated facial nerve grafts.
• ATM as a target for novel radiosensitizers.

Schools

---

• Drexel University College of Medicine

Conditions Treated

---

• Pituitary Gland Cancer
• Vulvar Cancer

Doctors Specialties

---

• Radiation Oncology

Accepted Insurances

---

Awards

---

• Gordon Conference Travel Award for presentation “Substrate screen for hChk1 and hChk2 kinase activity
• Chief Resident
• Jane Stuart Award for Excellence in Radiation Oncology and Nuclear Medicine
• Distinguished Academic Performance for Outstanding Academic Performance in the Field of Neoplastic Disease
• Distinguished Academic Performance for Outstanding Academic Performance in the Field of Radiation Therapy and Nuclear Medicine
• Alpha Omega Alpha, junior year
• Pathology Honor Society
• Measy Foundation Scholarship
• Deans Award for Research
• Class of 1955 Scholarship
• L. & M. Scholarship
• Dr. H. Malcolm Read Scholarship
• McMannis Scholarship

Education

---

• Mayo School of Graduate Medical Education
• Drexel University College of Medicine

Drug Facts

---

NPI NUMBER		1770561433
NPPES Provider LastName		ESHLEMAN
NPPES Provider FirstName		JEFFREY
NPPES Provider ZIPCode		176022250
NPPES Provider State		PA
Specialty Description		Radiation Oncology
Total Claim Count		32.0
Distinct Opioid Count		0.0
Opioid Claim Count		0.0
Percent Opioid Claims		0.0

Helpful Reviews

---

Give Anonymous Review

Medicare Facts

---

National Provider Identifier [NPI]	1770561433
Last Name Of The Provider	ESHLEMAN
First Name Of The Provider	JEFFREY
View All

Similar Doctors

---

	Dr. Roseann N. Romito, MD This Doctor is OpenDoctor Recommended.
	Dr. Kenneth G. Berkenstock, MD This Doctor is OpenDoctor Recommended.
	Dr. Kishor Singapuri, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Wallace A. Longton, MD This Doctor is OpenDoctor Recommended.
	Dr. Glenn B. Mieszkalski, MD This Doctor is OpenDoctor Recommended.
	Dr. Eileen F. McGarvey, MD

---

Doctor Directory | TOS | twitter | FB | Angel | blog